articleAmerican Journal of Geriatric PsychiatryOct 17, 2019Closed access

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3

RORachel Ochs-RossEDElla DalyYZYun ZhangRLRosanne LanePLPilar Lim

Janssen (United States) · Yale University · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

468
total citations
FWCI
50.79
Percentile
100%
References
43
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Placebo
  • Antidepressant
  • Depression (economics)
  • Medicine
  • Treatment-resistant depression
  • Nasal spray
  • Internal medicine
  • Clinical endpoint
UN Sustainable Development Goals
  • No poverty
No related works found for this paper.

Funding